The Taiwan Chip-based Industrial Innovation Program (Taiwan CbI) is a collaborative effort by various Taiwanese government ministries, leveraging Taiwan’s semiconductor expertise by integrating chips with key innovations. Startups should be focused on IC design innovations and Chip-based innovative applications in the following industries: data & security, mobility, sustainability, manufacturing and medtech.
Procter & Gamble is looking for new approaches and technologies that can help them to apply Generative AI to radically disrupt the efficiency and effectiveness of P&G brand building communication.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
Dilip Sundaram - Corporate Keynote
P&G is looking for partners and solutions that can support the automation of quality testing and preparation process at its Feminine Care manufacturing sites.
Following last year's successful Silicon Valley Showcase, MIT Startup Exchange is once again excited to feature this October countless advances in innovation, entrepreneurship and industry collaboration to impact not only how companies can do business but also how we function in our daily lives.
Join to hear from MIT faculty and MIT Startup Exchange entrepreneurs to learn how to navigate this new era with management best practices.